The Latest on TB and HIV
|
THRio Late Breaking Results from Rome IAS Conference
TB Preventive Therapy Reduces Disease and Death in People Living with HIV; Treatment is safe and effective — significant benefits at the community level.
July 2011 |
The CREATE mission is to reduce death and disease from TB in populations with high rates of HIV AIDS.
Representing researchers, clinicians, policy makers, AIDS/TB control programs, and the community at large, the CREATE Consortium is implementing research studies to assess the impact of bold, new public health paradigms for controlling the AIDS/TB epidemic.
Led by Dr. Richard Chaisson of the Johns Hopkins Center for Tuberculosis Research, CREATE hopes to transform global policies for TB/HIV through evidence-based advocacy.
We invite you to visit our studies, Thibela, THRio, ZAMSTAR to find out how they are progressing and what impact they will have in the future of TB/HIV policies and advocacy efforts.
To see all studies at a glance, click here. Or go to a particular study on your right to learn more.
